<PAGE>
EXHIBIT 99.46
SUPREME COURT OF THE STATE OF NEW YORK
COUNTY OF NEW YORK
----------------------------------------X Index No. 00-603784
HARBOR FINANCE PARTNERS, on behalf :
of itself and all others similarly : Purchased and filed on:
situated, : September 1, 2000
:
Plaintiff, : Plaintiff designates
: New York County as
- against - : the place for trial
:
AXA FINANCIAL, INC., AXA GROUP, : JURY TRIAL DEMANDED
EDWARD D. MILLER, CLAUDE BEBEAR, :
JOHN S. CHALSTY, FRANCOISE COLLOC'H, :
HENRI DE CASTRIES, CLAUS-MICHAEL DILL, :
JOSEPH L. DIONNE, JEAN-RENE FOURTOU, :
DONALD J. GREENE, ANTHONY J. HAMILTON, :
JOHN T. HARTLEY, JOHN H.F. HASKELL, JR.,:
MICHAEL HEGARTY, NINA HENDERSON, : The basis of venue is
W. EDWIN JARMAIN, DIDIER : place of business of
PINEAU-VALENCIENNE, GEORGE J. : defendants
SELLA, JR., PETER J. TOBIN, :
and DAVE H. WILLIAMS, :
: Plaintiff resides in
: Dade County, Florida
:
Defendants. : S U M M O N S
----------------------------------------X
To the above named defendants:
YOU ARE HEREBY SUMMONED to answer the complaint in this action
and to serve a copy of your answer, or, if the complaint is not served with this
summons, to serve a notice of appearance, on the Plaintiff's Attorneys within 20
days after service of this summons, exclusive of the day of service (or within
30 days after the service is complete if this summons is not personally
delivered to you within the State of New York); and in case of your failure to
appear or answer, judgment will be taken against you by default for the relief
demanded in the complaint.
Defendants' address:
c/o AXA Financial, Inc.
1290 Avenue of the Americas
New York, New York 10104
Dated: September 1, 2000
WECHSLER HARWOOD HALEBIAN
& FEFFER LLP
By: /s/ Robert I. Harwood
---------------------------
Robert I. Harwood
488 Madison Avenue
New York, New York 10022
(212) 935-7400
Attorneys for Plaintiff
<PAGE>
SUPREME COURT OF THE STATE OF NEW YORK
COUNTY OF NEW YORK
-----------------------------------------x
:
HARBOR FINANCE PARTNERS, : Index No. 00-603784
individually And :
On Behalf Of A Class Of Persons :
Similarly Situated, :
:
Plaintiff, :
:
- against - :
:
AXA FINANCIAL, INC., AXA GROUP, : JURY TRIAL DEMANDED
EDWARD D. MILLER, CLAUDE BEBEAR, : -------------------
JOHN S. CHALSTY, FRANCOISE COLLOC'H, :
HENRI DE CASTRIES, CLAUS-MICHAEL DILL, :
JOSEPH L. DIONNE, JEAN-RENE FOURTOU, :
DONALD J. GREENE, ANTHONY J. HAMILTON, :
JOHN T. HARTLEY, JOHN H.F. HASKELL, JR., :
MICHAEL HEGARTY, NINA HENDERSON, :
W. EDWIN JARMAIN, DIDIER :
PINEAU-VALENCIENNE, GEORGE J. :
SELLA, JR., PETER J. TOBIN, :
and DAVE H. WILLIAMS, :
:
Defendants. :
-----------------------------------------x
CLASS ACTION COMPLAINT
Plaintiff, individually and on behalf of all other persons similarly
situated, by its undersigned attorneys, for its consolidated class action
complaint, alleges upon personal knowledge as to itself and its own acts, and
upon information and belief as to all other matters, based upon, inter alia, the
investigation made by and through its attorneys, which investigation included,
among other things, a review of the public documents, published reports and news
articles, as follows:
NATURE OF THE ACTION
1. Plaintiff brings this action on behalf of itself and the public
shareholders of defendant AXA Financial, Inc. ("AXA" or the "Company") a
majority owned subsidiary of defendant AXA
<PAGE>
I.
Group, ("AXA Group"), its French parent, to enjoin a proposed coercive,
deceptive and fraudulent minority freeze out ("the buy out") of the public
shareholders of the Company via an inadequate offer by defendant AXA Group or,
in the alternative, to obtain rescission or damages if the buy out is
consummated.
2. Defendant AXA Group, which owns approximately 60% in AXA seeks to
eliminate the public shareholders of AXA by acquiring the remaining
approximately 40% of the Company that it does not own at a grossly inadequate
price of $53.50 per share or a total of $10.4 billion. Defendant AXA is
controlled by its majority shareholder. The Director Defendants identified below
owe the highest fiduciary duty to be scrupulously fair in their dealings with
the minority shareholders of AXA. The proposed buy out constitutes self dealing,
deception, unfair dealing, overreaching and a breach of fiduciary duty to AXA's
minority shareholders.
THE PARTIES
3. Plaintiff owns shares of AXA stock and has held such shares up to and
including the announcement of the proposed buy out.
4. Defendant AXA is a Delaware corporation with its principal place of
business at 1290 Avenue of the Americas, New York, New York. AXA is an
international group of insurance and related financial services companies. AXA's
insurance operations include activities in life insurance, property and casualty
insurance and reinsurance. As of May 17, 2000, AXA had
2
<PAGE>
approximately 432,000,000 shares outstanding, which are traded on the New York
Stock Exchange.
5. Defendant AXA Group, AXA's parent is organized under the laws of the
republic of France. Defendant AXA Group, by reason of its majority ownership and
control of AXA, is in a fiduciary relationship with plaintiff and the other
public shareholders of AXA, and owes to them the highest obligations of good
faith, loyalty and fair dealing and to avoid self-dealing transactions which
benefit themselves at the expense of the other shareholders of the Company.
Defendant AXA Group is sued herein because it has breached these fiduciary
duties.
6. Defendant Edward D. Miller ("Miller") is a director of the Company.
Miller was President and Chief Executive Officer of the Company since August
1997. He was President of Equitable Life from August 1997 to January 1998 and
has been Chairman of Equitable Life since January 1998 and Chief Executive
Officer and a Director of Equitable Life since August 1997. He is also a Member
of AXA's Management Board (since January 2000). Prior thereto, he was a Senior
Executive Vice President of AXA. From 1996 to 1997, he was Senior Vice Chairman
of Chase Manhattan Corporation. Prior thereto, he was President of Chemical Bank
(which merged with Chase in 1996) from 1994 to 1996 and Vice Chairman from 1991
to 1994. He is also a Director of various AXA Financial subsidiaries, including
Donaldson Lufkin & Jenrette ("DLJ") and Alliance Capital Management Corporation,
the general partner of Alliance Holding and Alliance; AXA Canada; and KeySpan
3
<PAGE>
Energy Corporation, formed as a result of the merger of Long Island Lighting
Company and Brooklyn Union Gas Co.
7. Defendant Claude Bebear ("Bebear"), formerly Chairman of the Board of
the Management (formerly Executive) Board (Chief Executive Officer) of AXA since
January 1997 is a director of the Company. Prior thereto, he was Chairman and
Chief Executive Officer of AXA from 1989 until January 1997 and Chief Executive
Officer from 1974 to 1989.
8. Defendant John S. Chalsty ("Chalsty"), Chairman of DLJ (since February
1996) is a director of the Company. Chalsty was Senior Executive Vice President
of AXA from January 1997 until January 2000, Chief Executive Officer of DLJ from
1986 to February 1998, and President of DLJ from 1986 to February 1996. Director
of DLJ since 1971 and Director of IBP, Inc., Sappi Limited, and Occidental
Petroleum Corporation. From 1990 to 1994 Chalsty served as Vice Chairman of the
New York Stock Exchange, Inc.
9. Defendant Francoise Colloc'h ("Colloc'h"), a director of the Company,
is a member of the AXA Management Board and Group Executive President, Human
Resources, Communication and Synergies of AXA since January 2000. Prior thereto,
she was Senior Executive Vice President (1993-2000), Executive Vice President
(1993), Senior Vice President-Management and Communication (1992), and a Vice
President (1984-1992) of AXA. She is also a Director or officer of various
subsidiaries and affiliates of the AXA Group. Colloc'h has been a director of
Equitable Life since July 1992.
4
<PAGE>
I.
10. Defendant Henri de Castries ("Castries") has been the Chairman of the
Board of the Company since April 1998, Vice Chairman from February 1996 to April
1998, Vice Chairman of AXA's Management Board (since January 2000), and a
director of the Company. Prior thereto, he was Senior Executive Vice President
Financial Services and Life Insurance Activities in the United States, Germany,
the United Kingdom and Benelux from 1996 to 2000; Executive Vice President
Financial Services and Life Insurance Activities from 1993 to 1996; General
Secretary from 1991 to 1993; and Central Director of Finances from 1989 to 1991
of AXA. Castries is also a Director or officer of various subsidiaries and
affiliates of the AXA Group. He is also a Director of DLJ and Alliance Capital
Management Corporation, the general partner of Alliance Holding and Alliance.
Castries has been a director of Equitable Life since September 1993.
11. Defendant Claus-Michael Dill ("Dill") is Chairman of the Management
Board of AXA Colonia Konzern AG and affiliated companies since June 1999 and a
director of the Company. Prior thereto, Dill was a member of the Management
Board of the same companies from April 1999 until June 1999, and a member of the
Holding Management Board of Gerling-Konzern from 1995 until April 1999. From
1988 until 1995, he was a member of the management boards of a number of Swiss
Reinsurance subsidiaries. He is also a member of the Executive Board of AXA, and
serves as Director or officer of various subsidiaries and affiliates of the AXA
Group. He is also a Member of the Supervisory Board of Deutsche
5
<PAGE>
Arzteversicherung AG, Kolnische Ruckversicherung-Gesellschaft AG and Rheinboden
Hypothekenbank AG.
12. Defendant Joseph L. Dionne ("Dionne") retired as Chairman of The
McGraw-Hill Companies in January 2000. Prior thereto, he held the positions of
Chairman and Chief Executive Officer of The McGraw-Hill Companies. In addition
to being a director of the Company, Dionne serves as a director of The
McGraw-Hill Companies, Harris Corporation and Ryder System, Inc. Dionne has
served as a director of Equitable Life since May 1982.
13. Defendant Jean-Rene Fourtou ("Fourtou"), a director of the Company,
has been a Vice Chairman of the Management Board of Aventis (formerly
Rhone-Poulenc, S.A.) since December 1999. Prior thereto, Fourtou was Chairman
and Chief Executive Officer of Rhone-Poulenc, S.A. from 1986 until December
1999. Fourtou is a member of the Supervisory Board of AXA. Fourtou also serves
as a director of Schneider Electric (formerly Schneider S.A.), Paribas, and
Groupe Pernod-Ricard. He is a member of the Consulting Council of Banque de
France and has been a director of Equitable Life since July 1992.
14. Defendant Donald J. Greene ("Greene"), a director of the Company, is
Of Counsel to LeBoeuf, Lamb, Greene & MacRae, L.L.P. Greene has been a director
of Equitable Life since July l99l.
15. Defendant Anthony J. Hamilton ("Hamilton") is a director of the
Company. Hamilton is Group Chairman and Chief Executive of Fox-Pitt, Kelton
Group Ltd., the London and New York
6
<PAGE>
based investment banking firm, which Hamilton joined in 1978. Hamilton is the
Non-executive Chairman of Byas, Mosley Group Ltd. and a director of various
Fox-Pitt, Kelton and Byas, Mosley Group companies. He is also a member of the
Supervisory Board of AXA and Director of Sun Life & Provincial Holdings plc.
Hamilton was a director of Equitable Life from December 1995 until June 1996.
16. Defendant John T. Hartley ("Hartley") retired as Chairman and Chief
Executive Officer of Harris Corporation in July 1995. He also serves as a
director of Harris Corporation and The McGraw-Hill Companies and has been a
director of Equitable Life since August 1987.
17. Defendant John H.F. Haskell, Jr. ("Haskell") is a director of the
Company. Haskell has been a Senior Advisor of Warburg Dillon Read LLC since
1999. Prior thereto, he was Managing Director and a member of its Board of
Directors. Haskell is a director of Pall Corporation, and was Chairman of the
Supervisory Board of Dillon Read (France) Gestion until 1998).
18. Defendant Michael Hegarty ("Hegarty") is a director of the Company.
Hegarty has been a Senior Vice Chairman of the Company since November 1999 and
Chief Operating Officer since February 1998; Vice Chairman of the Company from
April 1998 to November 1999; and Senior Executive Vice President of the Company
from January 1998 to April 1998. Hegarty has also been a Director and President
of Equitable Life since January 1998 and Chief operating Officer since February
1998. From 1996 to 1997 Hegarty was Vice Chairman of Chase Manhattan
Corporation. Prior thereto,
7
<PAGE>
he was Vice Chairman (1995-1996) and Senior Executive Vice President (1991-1995)
of Chemical Bank, which merged with Chase in 1996. Hegarty is a member of the
Executive Board of AXA and a director of various AXA Financial subsidiaries.
19. Defendant Nina Henderson ("Henderson") is a director of the Company
and is Corporate Vice President of Core Business Development of Bestfoods. Prior
thereto, she was President of Bestfoods Grocery and Vice President of Bestfoods
from 1997 until 1999, and president of Bestfoods Specialty Markets Group from
1993 until 1997. Henderson also serves as a director of Hunt Corporation and
PACTIV Corporation (formerly known as Tenneco Packaging).
20. Defendant W. Edwin Jarmain ("Jarmain") is a director of the Company
and has been President of Jarmain Group Inc. since 1979. He also serves as an
officer or director of several affiliated companies. Jarmain is a director of
Equitable Life, DLJ, AXA Insurance (Canada), Anglo Canada General Insurance
Company, and AXA Pacific Insurance Company, and an Alternate Director of AXA
Asia Pacific Holdings Limited. He served as non-executive Chairman and Director
of FCA International Ltd. from January 1994 until May 1998 and has been a
director of Equitable since July 1992.
21. Defendant Didier Pineau-Valencienne ("Pineau-Valencienne") is a
director of the Company. He is Vice Chairman of Credit Suisse First Boston. From
1981 to February 1999, he was Chairman and Chief Executive Officer of Schneider
Electric, of
8
<PAGE>
which he became Honorary Chairman in February 1999. Pineau-Valencienne was a
director of the Company and Equitable Life from July 1992 to February 1995, a
member of the Supervisory Board of AXA, director of CGIP, Aventis (formerly
Rhone-Poulenc, S.A.), Sema Group PLC (UK), Soft Computing, and Swiss Helvetic
Fund; and a member of the Advisory Board of Booz-Allen & Hamilton. He has also
served as a director of Equitable Life since February 1996.
22. Defendant George J. Sella, Jr. ("Sella") is a director of the Company.
Sella retired as Chairman and Chief Executive Officer of American Cyanamid
Company in April 1993. He also serves as a director of Coulter Pharmaceutical
and a director of Equitable Life.
23. Defendant Peter J. Tobin ("Tobin") is a director of the Company. Tobin
is the dean of the Peter J. Tobin College of Business Administration of St.
John's University since August 1998. He was Chief Financial Officer at Chase
Manhattan Corporation from 1996 to 1997. Prior thereto, he was Chief Financial
Officer of Chemical Bank (which merged with Chase in 1996) from 1991 to 1996. He
is a director of The CIT Group, Inc., H.W. Wilson Company and P.A. Consulting
and has been a director of Equitable Life since March 1999.
24. Defendant Dave H. Williams ("Williams") is a director of the Company.
Williams is Chairman of the Board of Directors of Alliance Capital Management
Corporation ("Alliance") and is Chairman or a director of numerous subsidiaries
and affiliates of Alliance. He was Senior Executive Vice President of
9
<PAGE>
AXA from January 1997 until January 2000. Williams has been a director of
Equitable Life since March 1991.
25. The defendants listed in paragraphs 6 through 24 are hereinafter
referred to as the "Individual Defendants." The Individual Defendants, by reason
of their corporate directorship and/or executive positions, are fiduciaries to
and for the Company's shareholders, which fiduciary relationship requires them
to exercise their best judgment, and to act in a prudent manner and in the best
interests of the Company's shareholders.
26. Each Individual Defendant herein is sued individually as a conspirator
and aider and abettor, as well as in his capacity as an officer and/or director
of the Company, and the liability of each arises from the fact that he has
engaged in all or part of the unlawful acts, plans, schemes, or transactions
complained of herein.
CLASS ACTION ALLEGATIONS
27. Plaintiff brings this action on its own behalf and as a class action
on behalf of all AXA shareholders as of August 30, 2000 and their successors in
interest (the "Class"), who are or will be deprived of their equity interest in
AXA at an unfair price under the proposed buy out of the Company's public
shareholders through the wrongful acts described herein. Excluded from the Class
are defendants herein and any person, firm, trust, corporation or other entity
related to or affiliated with defendants.
10
<PAGE>
28. This action is properly maintainable as a class action pursuant to
CPLR 901 for the following reasons:
a. The Class of AXA shareholders for whose benefit this action is
brought is so numerous that joinder of all Class members is impracticable.
There are more than 432,000 shares of the Company's stock outstanding,
approximately 40% of which are held by the public.
b. There are thousands holders of record of the Company's common
stock, hundreds of which were holders of record in the United States. The
exact current number of Class members is unknown to plaintiff at this time
and can only be ascertained through appropriate discovery.
c. There are questions of law and fact which are common to members of
the Class and which predominate over any questions affecting only
individual members. The common questions include, inter alia, the
following:
(1) whether defendants have engaged in a plan and scheme to
deceive and coerce the minority public shareholders of AXA to sell
their shares at a grossly inadequate price and to enrich themselves at
the expense of these public minority shareholders;
(2) whether the proposed freeze-out is grossly unfair to the
Company's minority public shareholders;
(3) whether defendants have engaged and are continuing to engage
in a plan and scheme to eliminate the Company's minority public
shareholders through unfair means and devices;
(4) whether defendants are engaged in self-dealing by reason of
the proposed acquisition;
11
<PAGE>
(5) whether the directors of the Company are independent of AXA
Group or have a disabling conflict of interest;
(6) whether plaintiff and the other members of the Class would be
irreparably damaged were the transactions complained of herein
consummated; and
(7) whether defendants have breached the fiduciary and other
common law duties owed by them to plaintiff and the other members of
the Class.
d. Plaintiff is committed to prosecuting this action and has retained
competent counsel experienced in litigation of this nature. Plaintiff's
claims are typical of the claims of the other members of the Class and
plaintiff has the same interests as the other members of the Class.
Accordingly, plaintiff is an adequate representative of the Class and will
fairly and adequately protect the interests of the Class.
SUBSTANTIVE ALLEGATIONS
29. On August 30, 2000, AXA Group announced that it would acquire all of
the outstanding shares of AXA it did not already own. Under the proposal, AXA
shareholders would receive consideration consisting of $32.10 in cash and 0.1271
of an AXA Group American Depositary share with a total purported value of $53.50
per AXA share. This announcement was made following a phenomenal year of growth.
The stock price has risen by 54%.
30. The buy out proposal is contingent on the completion of a previously
announced transaction whereby AXA would sell its 71% interest in DLJ to Credit
Suisse Group of Zurich.
12
<PAGE>
31. In response to the announcement of the offer, AXA stock rose 6 cents
per share to $52.38. Several analysts following the Company downgraded their
ratings of AXA on August 31, 2000.
32. The offered consideration is grossly inadequate and unfair in light of
the Company's financial performance and future prospects and the current and
projected market value of AXA's shares. As reported in the financial media by
numerous analysts including Morningstar.com, AXA beat earnings estimates and
reported second quarter net revenues of $2.8 billion. An August 2, 2000,
Morningstar.com wire story characterized the Company's long-term fundamentals as
"compelling."
33. Obtaining control over the Company will provide substantial financial
benefits to AXA Group, which benefit is not reflected in the buy out offer to be
made to AXA's minority shareholders. Thus, the AXA Group is seeking to eliminate
AXA's public shareholders at a grossly inadequate and unfair price.
34. Defendants AXA Group as the majority controlling shareholders of the
Company, and the Individual Defendants, owe the Company's minority public
shareholders the highest duty of loyalty, honesty and fairness. These defendants
have breached their fiduciary duties to the minority shareholders by not having
AXA Group offer a fair price to the minority.
35. Because AXA Group owns a majority of the equity of AXA, it would be
practically impossible for any other bidder to fairly bid for control of AXA
without its consent and cooperation.
13
<PAGE>
36. The proposed consideration to be paid to the public shareholders is
grossly unfair, inadequate and substantially below the fair or inherent value of
AXA. Its value is materially greater than the consideration being offered,
taking into account the Company's financial results, the strength of its
business, its future prospects, its assets and earnings power, as well as its
market price.
37. The proposed transaction will deny plaintiff and other Class members
their rights to share proportionately in the true value of AXA's assets and
future growth in profits and earnings. AXA Group intend to appropriate these
assets and the ongoing business for themselves at a price which is substantially
less than its fair market value.
38. The proposed consideration is not the result of arm's-length
negotiations and is not based upon an independent evaluation of the current
value of the Company's assets or business, but was fixed arbitrarily as part of
defendants' unlawful plan and scheme to obtain AXA at the lowest possible price.
39. Defendants are not acting in good faith toward plaintiff and the
Class; have breached and are breaching their fiduciary duties to plaintiff and
the Class; and have willfully participated in unfair dealing toward plaintiff
and the Class.
40. As a result of the actions of the defendants, plaintiff and other
members of the Class have been and will be damaged in that they are the victims
of unfair dealing and are not receiving the fair value of their interests in the
Company.
14
<PAGE>
41. Unless enjoined by this Court, defendants will continue to breach
their fiduciary duties owed to plaintiff and the Class, and will succeed in
their plan to enrich themselves by excluding plaintiff and other members of the
Class from their fair proportionate share of the Company, all to the irreparable
harm of plaintiff and the Class.
42. The acts and transactions causing injury to plaintiff and the Class
have occurred and will occur in this district if the proposed merger is
consummated.
43. Plaintiff and the Class have no adequate remedy at law.
WHEREFORE, plaintiff, on behalf of itself and the Class, pray for judgment
and relief as follows:
A. Declaring this action to be a proper class action and certifying
plaintiff as the representative of the Class;
B. Declaring that defendants have committed a gross abuse of trust and
have breached their fiduciary and other duties to plaintiff and other members of
the Class;
C. Enjoining defendants and their counsel, agents, employees and all
persons acting under, in concert with, or for them, from proceeding with,
consummating or closing the proposed buy out;
D. In the event the proposed buy out is consummated, rescinding it and
setting it aside or granting plaintiff and the other members of the Class
rescissionary damages;
15
<PAGE>
E. Requiring defendants to account to plaintiff and the Class for all
profits obtained from the breaches of fiduciary duty alleged herein;
F. Awarding plaintiff and the Class compensatory damages, together with
appropriate prejudgment interest at the minimum rate allowable by law;
G. Awarding plaintiff and the Class their costs and expenses for the
litigation, including reasonable attorneys' fees and other disbursements; and
H. Granting such other and further relief as this Court deems to be
necessary and appropriate.
Dated: New York, New York
September 1, 2000
WECHSLER HARWOOD HALEBIAN
& FEFFER LLP
By: /s/ Robert I. Harwood
-----------------------------
Robert I. Harwood
488 Madison Avenue, 8th Floor
New York, NY 10022
(212) 935-7400
Attorneys for Plaintiff
16
<PAGE>
SUPREME COURT OF THE STATE OF NEW YORK
COUNTY OF NEW YORK
================================================================================
HARBOR FINANCE PARTNERS, individually : Index No.
And On Behalf Of A Class Of Persons Similarly Situated, : 00-603784
:
Plaintiff, :
- against - :
:
AXA FINANCIAL, INC., AXA GROUP, :
EDWARD D. MILLER. CLAUDE BEBEAR, :
JOHN S. CHALSTY, FRANCOISE COLLOC'H, :
HENRI DE CASTRIES, CLAUS-MICHAEL DILL, :
JOSEPH L. DIONNE, JEAN-RENE FOURTOU, :
DONALD J. GREENE, ANTHONY J. HAMILTON, :
JOHN T. HARTLEY, JOHN H.F. HASKELL, JR., :
MICHAEL HEGARTY, NINA HENDERSON, W. EDWIN :
JARMAIN, DIDIER PINEAU-VALENCIENNE, GEORGE J. :
SELLA, JR., PETER J. TOBIN, and DAVE H. WILLIAMS, :
Defendants. :
================================================================================
SUMMONS AND COMPLAINT
================================================================================
WECHSLER HARWOOD HALEBIAN & FEFFER LLP
Attorneys for Plaintiff
488 MADISON AVENUE
NEW YORK. N.Y. 10022
(212) 935-7400
================================================================================
To: Service of a copy of the within
is hereby admitted.
Dated __________________________
________________________________
Attorney(s) for
================================================================================
PLEASE TAKE NOTICE:
|_| NOTICE OF ENTRY
that the within is a (certified) true copy of an
duly entered in the office or the clerk of the within named court on
|_| NOTICE OF SETTLEMENT
that an , of which the within is a
true copy, will be presented for settlement to the Hon.
one of the judges of the within named Court, at
on , at
Dated:
Yours, etc.
WECHSLER HARWOOD HALEBIAN & FEFFER LLP
Attorneys for
411 MADISON AVENUE
To: NEW YORK, N.Y. 10022
Attorneys for (212) 935-7400
